METASTATIC BRAIN CANCER

A PHASE II MULTICENTER, EXPLORATORY STUDY, EVALUATING THE TREATMENT EFFECT OF SURGERY PLUS GLIADEL WAFER IN PATIENTS WITH METASTATIC BRAIN CANCER GLIA-001

Eligibility Criteria

At least 18 years of age

Metastatic brain cancer with a primary diagnosis of non-small cell lung cancer, breast cancer, melanoma, renal cancer, colon cancer, or unknown primary cancer

A single brain metastasis (at least one tumor in your brain) for which surgical resection is planned